The objective of this KDIGO conference is to gather a global multidisciplinary panel of nephrologists, rheumatologists, pathologists, immunologists, and cell therapists to address the therapeutic strategy of targeting of B-cells for the management of autoimmune and immune-mediated kidney diseases.  The goal of this KDIGO conference is to review the efficacy and safety of B cell-targeted approaches directed at the underlying drivers of disease and to assess how they supplement or replace existing management paradigms.

Drs. Jürgen Floege (University of Aachen, Germany) and Brad Rovin (Ohio State University, USA) will co-chair this conference.